Vivus' experimental weight-loss drug Qnexa helped 449 participants lose 10% of their initial body weight after two years, compared with a 2% weight reduction in 227 of those who took a placebo, a study in the American Journal of Clinical Nutrition found. Qnexa-treated patients also had better blood glucose and insulin levels and were less likely than their placebo-treated counterparts to develop diabetes.

Full Story:

Related Summaries